Sarepta Therapeutics
SRPT
SRPT
423 hedge funds and large institutions have $11.2B invested in Sarepta Therapeutics in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 150 increasing their positions, 134 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
423
Holders Change
+14
Holders Change %
+3.42%
% of All Funds
6.77%
Holding in Top 10
12
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.69%
% of All Funds
0.19%
New
69
Increased
150
Reduced
134
Closed
52
Calls
$489M
Puts
$467M
Net Calls
+$21.9M
Net Calls Change
-$103M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$510M |
| 2 |
BC
2
Boxer Capital
San Diego,
California
|
$107M |
| 3 |
3
Two Sigma Advisers
New York
|
$162M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$503M |
| 5 |
5
Artisan Partners
Milwaukee,
Wisconsin
|
$60.4M |
